Skip to main content
logo
Gujarat Terce Laboratories Limited (BOM:524314)
India flag India · Delayed Price · Currency is INR
34.30
-0.60 (-1.72%)
At close: Jul 28, 2026

BOM:524314 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
474.73474.73501.95479.75467.83401.34
Revenue Growth
-5.84%-5.42%4.63%2.55%16.57%59.40%
Gross Profit
303.39303.39310.32302.22274.02246.85
Operating Income
33.2533.2534.988.99-25.248.42
Net Income
22.0222.02-9.792.44-16.728.72
Earnings Per Share
2.922.92-1.320.33-2.251.18
EPS Growth
-17.29%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
42.0842.0812.910.920.315.09
Total Debt
12.9612.969.4238.6772.7266.72
Net Cash (Debt)
29.1129.113.49-37.77-52.42-51.63
Net Cash Growth
-734.18%----
Net Cash Per Share
3.863.860.47-5.09-7.06-6.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
17.1517.1530.59260.27-4.43
Capital Expenditures
-0.31-0.31--0.74-0.63-21.14
Free Cash Flow
16.8416.8430.5925.26-0.36-25.57
Free Cash Flow Growth
60.45%-44.95%21.11%---

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
63.91%63.91%61.82%63.00%58.57%61.51%
Operating Margin
7.00%7.00%6.97%1.87%-5.39%2.10%
Pretax Margin
6.39%6.39%6.75%1.13%-6.19%1.86%
Profit Margin
4.64%4.64%-1.95%0.51%-3.57%2.17%
FCF Margin
3.55%3.55%6.09%5.27%-0.08%-6.37%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
11.7510.94-161.36-22.25
P/FCF Ratio
15.8714.3014.8315.55--
PS Ratio
0.560.510.900.820.260.48